OUTLINE Embryology Types of neural tube defects Possible Risk Factors Clinical features Investigation Associated anamolies Management
TYPES Open anencephaly, encephalocele, spina bifida, hydrencehaly , iniencephaly . Closed lipomyelomeningocele , lipomeningocele , and tethered cord.
ENENCEPHALY There is absence of cranial vault with cerebral hemispheres completely absent or greatly reduced in size.
CRANIOSCHISIS A skull defect through which neural tissue protrudes.
EXANCEPHALY A protrusion of brain and meninges out of the skull.
RACHISCHISIS Meninges and spinal cord are exposed through a fissure in the vertebral column.
INIENCEPHALY There is retroflexion of the head without a neck and severe distortion of the spine.
HYDRENCEHALY T he cerebral hemispheres are absent and replaced by sacs filled with cerebrospinal fluid.
ENCEPHALOCELE A protrusion of brain and meninges into a fluid filled sac through a skull defect.
SPINA BIFIDA Incomplete closing of the spine and membranes around the spinal cord
RISK FACTORS Low intake of folic acid Ingestion of folate antimelabolities Gestational diabetes Obesity during pregnancy Arsenic poisoning R adiation Cigarette smoking
CLINICAL FEATURES Paralysis of the legs Partial or total lower body weakness Learning disabilities Visual impairment Stunted growth Mental retardation Difficulty in movement Facial defects Increased muscle tone Respiratory issue Progressive enlargement of the head Vomiting Nausea Coma Urinary and bowel dysfunction Cardiac abnormalities
WORKUP
PRENATAL DETECTION SERUM ALPHA-FETOPROTEIN (AFP) A high maternal serum AFP (≥ 2 multiples of the median for the appropriate week of gestation) between 15–20 weeks gestation carries a relative risk of 224 for neural tube defects
ULTRASOUND Prenatal ultrasound will detect 90–95% of cases of spina bifida In cases of elevated AFP, it can help differentiate NTDs from non-neurologic causes of elevated AFP (e.g. omphalocele ), and can help to more accurately estimate gestational age.
AMNIOCENTESIS Amniotic fluid AFP levels are elevated with open neural tube defects, with a peak between weeks 13–15 of pregnancy. Amniocentesis also carries a ≈ 6% risk of fetal loss in this population.
ASSOCIATED ANOMALIES
UROGENITAL & ORTHOPEDIC
TREATMENT Perinatal management In utero repair Conventional Surgery/ Open repair